Composites World / NetComposites

Connecting you to the composites industry

Advertisement

NetComposites Ltd has transferred the rights and ownership of this website to Gardner Business Media Inc.

On 1st January 2020, NetComposites' media assets including netcomposites.com, newsletters and conferences were transferred to Composites World (Gardner Business Media).

This site is no longer being updated. Please direct all enquiries to netcomposites@gardnerweb.com.

For further details see our joint press release.

Osteobiologics Receives Patent for Manufacturing Fibre-Reinforced Scaffolds

  • Thursday, 30th September 2004
  • 0 comments
  • Reading time: less than a minute

OsteoBiologics, Inc, an innovator in tissue repair technologies has released details for its fibre-reinforced biodegradable scaffolds patent.

The patent claims methods of manufacturing fibre-reinforced, polymeric implant materials useful for tissue engineering, specifically to facilitate regeneration of load-bearing tissues such as articular cartilage and bone. This new patent broadens existing OBI technologies for both porous and non-porous resorbable scaffolds useful as implants for load-bearing sites. OBI, through its patent portfolio, has the unique ability to combine porosity and load-bearing capabilities into single or multiphase bioresorbable implant devices.

“This patent represents continued expansion of our broad patent portfolio which has been our strategic goal as we develop advanced technologies for medicine,” said Fred Dinger, President and CEO of OBI. This patent supports the PolyGraf line of products, including the TruFi Plugs as well as other products currently in development.

OsteoBiologics, Inc, based in San Antonio, Texas, are a private company specialising in developing and manufacturing bioabsorbable polymeric scaffolds, films, and related instrumentation for the repair and replacement of bone, soft tissue and articular cartilage.


For more information visit:


Share this article


More News


Comments (0)

Leave your comment